1. Home
  2. MP vs TECH Comparison

MP vs TECH Comparison

Compare MP & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MP Materials Corp.

MP

MP Materials Corp.

HOLD

Current Price

$57.67

Market Cap

11.0B

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$53.84

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MP
TECH
Founded
2017
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
10.2B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
MP
TECH
Price
$57.67
$53.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
12
Target Price
$70.92
$73.09
AVG Volume (30 Days)
4.6M
2.0M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
0.57%
EPS Growth
12.28
N/A
EPS
N/A
0.49
Revenue
$331,952,000.00
$1,219,635,000.00
Revenue This Year
$114.18
$2.49
Revenue Next Year
$37.87
$6.40
P/E Ratio
N/A
$114.73
Revenue Growth
147.15
5.23
52 Week Low
$18.64
$46.02
52 Week High
$100.25
$72.16

Technical Indicators

Market Signals
Indicator
MP
TECH
Relative Strength Index (RSI) 46.39 33.02
Support Level $51.73 $48.52
Resistance Level $65.27 $54.08
Average True Range (ATR) 3.47 2.26
MACD 0.14 -0.27
Stochastic Oscillator 40.66 3.86

Price Performance

Historical Comparison
MP
TECH

About MP MP Materials Corp.

MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America. The company is also developing a rare earth metal, alloy, and magnet manufacturing facility in Fort Worth, Texas. The company's operations are organized into two reportable segments: Materials and Magnetics.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: